Tiliroside
Tiliroside shows anticarcinogenic activity. Tiliroside shows hepatoprotective activity. Tiliroside shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders. Tiliroside has anti-diabetic effect, are at least partially mediated through inhibitory effects on carbohydrate digestion and glucose uptake in the gastrointestinal tract. Tiliroside and gnaphaliin are antioxidants against in vitro Cu (2+) -induced LDL oxidation in the same order of magnitude compared to that of the reference drug, probucol. Tiliroside enhances fatty acid oxidation via the enhancement adiponectin signaling associated with the activation of both AMP-activated protein kinase and peroxisome proliferator-activated receptor α and ameliorates obesity-induced metabolic disorders.
Product Specifications
CAS Number
20316-62-5
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (420.51 mM)
Smiles
C1=CC (=CC=C1C=CC (=O) OCC2C (C (C (C (O2) OC3=C (OC4=CC (=CC (=C4C3=O) O) O) C5=CC=C (C=C5) O) O) O) O) O
Molecular Formula
C30H26O13
Molecular Weight
594.52
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Clostridium Thermocellum rplV Protein (aa 1-125)
BRDT (BrdT, Cancer/Testis Antigen 9, CT9, RING3-like Protein) discontinued